Ex vivo wounded human skin organ culture is an invaluable tool for translationally relevant preclinical wound healing research. However, studies incorporating this system are still underutilized within the field because of the low throughput of histological analysis required for downstream assessment. In this study, we use intravital fluorescent dye to lineage trace epidermal cells, demonstrating that wound re-epithelialization of human ex vivo wounds occurs consistent with an extending shield mechanism of collective migration. Moreover, we also report a relatively simple method to investigate global epithelial closure of explants in culture using daily fluorescent dye treatment and en face imaging. This study is the first to quantify healing of ex vivo wounds in a longitudinal manner, providing global assessments for re-epithelialization and tissue contraction. We show that this approach can identify alterations to healing with a known healing promoter. This methodological study highlights the utility of human ex vivo wounds in enhancing our understanding of mechanisms of human skin repair and in evaluating novel therapies to improve healing outcome.
Experimentally wounded human skin organ culture has proven to be an invaluable tool for translationally relevant preclinical research for the past 20 years. 1 Many different groups have now developed similar approaches to understand basic mechanisms of human wound healing and for identifying novel candidate wound healing promoters. [2] [3] [4] [5] [6] [7] [8] In addition, assays using porcine skin ex vivo have been established [9] [10] [11] because of its anatomical similarity and strong concordance with human healing. 12 Reconstituted skin cultures (also known as organotypic or skin equivalent cultures), which comprise keratinocytes seeded onto a fibroblast-containing collagen gel, are also available to model human wounds. [13] [14] [15] Both skin explant and skin equivalent approaches display epithelial migration across the underlying matrix to heal the wound, although ex vivo skin is thought to mimic the in vivo situation more closely. 16, 17 Injury to artificial skin equivalent cultures initiates collective cell migration and wounds re-epithelialize through the formation of an extending shield, 14 although resolving whether this same mechanism is conserved in the much more complex environment found in human skin is yet to be addressed.
The accurate measurement of wound re-epithelialization in 3D experimental models has proved challenging as a result of high workload required to serially section the entire tissue, which is essential to ensure that the center of each wound is assessed. In addition, standard histology only provides a snapshot through the wound, and so, it is unclear how consistent the evaluated region might be to other areas within the wound.
Macroscopic assessment of wound closure forms the primary assessment for progression of healing in chronic wounds, given that biopsies may further jeopardize healing. 18 Thus, current ex vivo models typically examine wound healing in an entirely different plane to "real-life" observations made in the clinic.
Several recent studies have reported imaging the surface of ex vivo and organotypic wound cultures, using a range of different methods, which exploit differing spectroscopic properties of the various wound cell types. These include the use of infra-red and Raman spectroscopy, 19 measuring ultraviolet (UV) auto-fluorescence, 8 magnetic resonance imaging, 20 and revealing wound topography using fringe projection. 21 In addition, the recent article in Wound Repair and Regeneration by Glinos et al. 22 describes optical coherence tomography (OCT) as a method to differentiate newly formed epithelial tissue from open wound in human wounds ex vivo and provides the highest clarity of imaging reported thus far.
In our recent experiments, we have established a serumfree ex vivo human partial thickness wound model (see Methods for full details). We have been examining the green Wound Rep Reg (2019) 27 126-133 © 2018 by the Wound Healing Society fluorescent cell tracker dye 5-chloromethylfluorescein diacetate (CMFDA), which is taken up by viable cells in culture, 14 permitting lineage tracing experiments to understand the wound re-epithelialization process in human skin. Moreover, dye uptake can also be visualized under an upright fluorescent microscope, 23 and using this simple approach, we have optimized a method to produce a high clarity of wound imaging, approaching cellular levels of resolution. We have for the first time been able to track daily wound re-epithelialization changes of individual human wounds ex vivo over 6 days. Our study provides a simple assay that can evaluate drug responses in human wounds ex vivo, where the study of healing progression can be made longitudinally.
METHODS
Human skin was obtained with informed written consent from female donors undergoing elective abdominal surgery conducted at the University of Manchester following institutional ethical review.
Subcutaneous fat was removed, and 6-mm-diameter fullthickness skin biopsies were taken, containing a 2-mm diameter partial thickness wound, removing the epidermis and papillary dermis ( Figure 1A ). Any explants displaying an inconsistent size or depth of wound were excluded prior to culture. Explants were cultured at an air-liquid interface by placing each explant in a six well plate upon two absorbent pads (Millipore, Watford, UK) and a 0.45 μM nylon membrane (Millipore, Watford, UK) ( Figure 1B ). Two milliliter of William's E media (Life Technologies, Birchwood) supplemented with 1% penicillin/streptomycin, 2 mM L-Glutamine, 10 μg/mL insulin, and 10 ng/mL hydrocortisone (all supplements from Sigma-Aldrich, Gillingham, UK) was added to each well. Positive control explants were cultured with 10% fetal bovine serum (FBS; Life technologies, Birchwood, UK) supplemented to the media. Cultures were grown at 37 C with 5% CO 2 . Each day excess media was removed from the well and replaced with 1 mL fresh media.
Four microliters of 25 μM CMFDA (or CMTPX) (ThermoFisher Scientific, Loughborough, UK) was added to the wound surface for 30 minutes, then washed dropwise with phosphate buffered saline. For cell viability studies, 1 μg/mL of propidium iodide (PI) was cotreated alongside CMFDA. Planimetric imaging was conducted using a Leica M205 FA upright Stereomicroscope using a 5x/0.50 pLANapo LWD objective at the equivalent of 64x magnification and captured using a DFC 565FX (Leica, Wetzlar, Germany) camera through LAS AF v3.1.0.8587 software (Leica, Wetzlar, Germany). Specific band-pass filter set for green fluorescent protein was used. (Leica, Wetzlar, Germany) ( Figure 1C ).
For wound closure experiments fluorescent imaging with CMFDA was conducted daily. Fluorescent images were assessed using Image J (Fiji) for the area of the initial wound at day 0 (IW 0 ). On subsequent days (where day is denoted by n), the area of initial wound (IW n ) and the area of open wound remaining (OW n ) were measured (see Supporting Information Figure S1A ). Epithelial wound closure was calculated from measurements of area of initial wound, and the open wound remaining and expressed either as the % of wound closure on each day or on the area of healing achieved on each day in square millimeter. Percentage closure = 100 − (OW n /IW 0 × 100). Area healed = IW 0 − OW n .
Tissue contraction was calculated by assessing changes to the initial wound defect over the wound healing period. Tissue contraction = 100 -(IW n /IW 0 × 100).
In addition, the neo-epidermis was further assessed by measuring the area of the dim band of epidermal tissue toward the migrating front and the remaining brighter area (Supporting Information Figure S1A ). Tissue from five individual donors was used, with three to four explants per donor used for each treatment. The mean value of the three to four replicate explants per donor used for analysis (i.e., assessed as n = 5 replicate experiments from separate donors). A two-way analysis of variance (ANOVA) with repeated measures was used to analyze percentage wound closure, area healed, and contraction between FBS and control groups, over the 6 days in culture. This analysis allowed for a statistical evaluation of differences in healing as a result of timepoint or treatment group. In addition, the interaction between the two processes determined whether the evolution of healing response over time differed between treatment groups. Our analysis makes the assumption that our data are normally distributed.
Comparisons of % closure at an individual timepoint (day 2 or day 4) was assessed via a paired t test (GraphPad Prism 7.0, San Diego, CA). For all tests p < 0.05 was considered significant.
For histological imaging, tissue was formalin fixed for 24 hours and processed for paraffin wax embedding. Five micrometer sections were cleared with Xylene and rehydrated to water, then either stained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Fluorescence microscopy) or hemotoxylin & eosin (H&E; brightfield). Immuno-labeling with anti-keratin 1 (Abcam Cambridge, UK; Ab81623), anti-involucrin (Abcam; Ab53112), anti-occludin (Abcam; 168,986), and anti-loricrin (Abcam; Ab85679) antitobodies was performed at 1:1000 (keratin 1, loricrin, involucrin) or 1:250 (occludin) dilution overnight at 4 C following heat-mediated retrieval with 10 mM sodium citrate, pH 6.0, and blocking with 10% goat serum for 30 minutes. Localization was visualized with AlexaFluor594 tagged goat anti-mouse (keratin 1) or goat antirabbit (occludin, involucrin, and loricrin) secondary antibody (Life Technologies), with DAPI counterstaining. Images of stained sections were captured using a BZ-9000 microscope (Keyence, Osaka, Japan).
RESULTS

Vital dyes label epithelial cells within wounds and reveal cellular migration patterns during repair
To examine cell tracker dye uptake within human ex vivo wounds in situ, we first conducted histology to validate our approach, using wounds treated topically at day 0 with the green live cell tracker dye CMFDA. In addition, given CMFDA should only mark viable cells, the membrane impermeable nuclear dye PI was cotreated to identify any cells with damaged plasma membranes. Our data showed that only epithelial cells around the edge of the wound were labeled (Figure 2A ). We observed some PI positive nuclei directly at the injury site, which did not express CMFDA. A band of CMFDA labeled both basal and suprabasal epidermal cells adjacent to the wound, extending several cells away from the injury site. When these treated wounds were cultured until day 1, we did not find any PI positive nuclei remaining within the wound epidermis ( Figure 2B ). Day 0 CMFDA-labeled cells traced to the suprabasal portion of the emerging epithelial tongue on day 1, with the basal neoepidermal cells entirely unlabeled ( Figure 2C ), although these cells were able to uptake CMFDA when dye was administered on day 1 before harvesting ( Figure 2C ). Tracing CMFDA for longer revealed that the label became restricted to a portion of the outermost neo-epidermis toward the periphery of the wound ( Figure 2C ). Wounds treated on day 0 with CMFDA and then on day 1 with an equivalent red cell tracker dye CMTPX confirmed that cells at the tip of the epidermal front on day 1 were those not labeled on day 0 ( Figure 2D and inset 1) . Moreover, in the region proximal to wound edge, the CMTPX was restricted to the outermost surface of the neo-epidermis, where some overlap to those cells labeled on day 0 was observed ( Figure 2D and insets 2 and 3) . Occasionally, a few cells labeled on day 0 could be observed at late stages in the neoepidermis, and frequently these had a dendritic morphology ( Figure 2E ). Collectively, our data indicate that the basal cells present in close proximity to the injury at day 0 are selected to undergo maturation, while basal cells of the neoepidermis were composed of cells that were initially further away from the wound ( Figure 2F ). These data show strong agreement with an "extending shield mechanism" for epithelial repair as reported in skin equivalent wounds. 14 
Fluorescent vital dye can longitudinally monitor wound closure of human ex vivo wounds
Over the course of our cell tracing experiments, we found that using daily treatments of CMFDA, the entire surface of the neo-epidermis becomes labeled ( Figure 3A ). With this labeling approach, we then optimized a method to visualize the CMFDA-stained wound tissue of explants in culture, using an upright fluorescent microscope (see Methods and Figure 1C ). This technique differentiated the neo-epidermis from areas of open wound and the surrounding unwounded tissue, without the need for histology ( Figure 3B ). The newly laid epidermis of these wounds in culture is not obvious using conventional brightfield microscope (Supporting Information Figure S1B ). Using daily CMFDA treatments, we conducted en face imaging to monitor wound closure within individual wounds over 6 days ( Figure 3C ). Moreover, we compared our standard serum-free explants (Control; CTL) to those cultured in the presence of 10% FBS, to determine whether significantly accelerated repair could be correctly detected in our model. 3 Our data not only show that epithelial healing can be monitored daily intra-vitally but also revealed a clear divergence in the evolution of repair with the addition of FBS (i.e., the interaction between time and treatment factors), when we evaluated the % epithelial closure ( Figure 3D ) or the area of healed epidermis ( Figure 3E ). Measuring the explants each day also revealed that some wound contraction occurs over time ( Figure 3F ). However, this only accounted for around 20% of total healing observed, indicating that reepithelialization provides the major healing mechanism. The level of contraction between control and FBS-treated wounds was unchanged ( Figure 3F ).
The rate of healing between individual donors was variable; although a response to FBS was reproducible and detected significant differences to healing at individual timepoints, confirming the reliability of the model ( Figure 3G ).
Regions of newly laid and more mature epidermis can be determined
Our daily imaging identified distinct areas of epidermal healing with a band of dim CMFDA expression toward the Figure 2 . Epithelial repair of human ex vivo wounds progresses via an extending shield mechanism. Human ex vivo wounds were cultured in the presence of the fluorescent dyes. CMFDA and PI cotreatment at time of injury (D0) identifies live (CMFDA; green) and dead (PI; red) cells around the injury site (A), and these wounds traced to day 1 indicate PI-labeled cells are no longer present (B). CMFDA was treated at different times to examine how epithelial cells migrate, indicating that basal cells labeled on day 0 become progressively suprabasal. Treating with CMFDA on day 0 and on day 1 (inset 1) with the red cell tracker CMTPX reveals previously unlabeled cells at the epidermal tip (C). Labeled cells with a dendritic morphology were occasionally found in the neo-epidermis at later timepoints (E). Our data suggest an extending shield mechanism of repair whereby basal cells migrate from the surrounding epidermis (F). Bar =100 μm (A-D), 20 μm (E and inset images). Dotted line denotes basement membrane.
epidermal front, with brighter areas nearer to the margin ( Figure 4A ). As the CMFDA dye accumulates over time with our daily dosing regimen, and based on our observations with CMFDA and CMPTX dual labeling (Figure 2) , we hypothesized that bright regions indicated cells that had been labeled early (and probably several times), while dim areas likely reflected newly laid tissue that was not labeled until a late timepoint. We therefore wondered if these areas could define cornified and noncornified regions of the healing epidermis, as recently described to occur in human Figure 3 . Daily en face fluorescent imaging longitudinally assesses epithelial healing. Daily treatments of human ex vivo wounds with CMFDA labeled the entire length of neo-epidermis (A), which could also be visualized in en face images using an upright fluorescent microscope (B). Wounds cultured with 10% FBS compared to standard media control arm were examined with daily en face imaging to track epithelial formation over time (C). Quantification revealed a significant acceleration with FBS in the % epithelial closure (D) and the area of neo-epidermis (E). Slight contraction was observed of the wounds in culture, although there was no difference between FBS or control wounds (F). Paired analysis demonstrates the variability in healing between donors, but that the FBS response is reproducible (G). Data in D-F were analyzed using two-way ANOVA with repeated measures, while G used a paired t test. Graphs show mean AE SEM in D-F and in G the mean of each individual donor (n = 5 donors). *p < 0.05, ***p < 0.001, ****p < 0.0001. Bar = 1 mm (A), 100 μm (B), and 500 μm (C). [Color figure can be viewed at wileyonlinelibrary.com] ex vivo wounds. 22 To further explore this, we conducted histology of serial sections to compare H&E morphology to the CMFDA intensity, where we found that the bright cells showed a granular appearance, while stratum corneum could often also be identified within the neo-epidermis within the CMFDA bright cell population ( Figure 4B ). Next, we conducted immunofluorescence for the suprabasal keratinocyte marker keratin 1, confirming that the front of epithelial healing was devoid of keratin 1 positive keratinocytes, whereas within the dim region, keratin 1 positive cells emerged in the suprabasal layer, suggesting that cell differentiation commences relatively quickly ( Figure 4C ). The brighter region showed Figure 4 . CMFDA en face imaging identifies regions of neo-epidermis with bright and dim expression. Daily en face imaging shows regions of dim and bright CMFDA intensity (A). Histology identifies mature stratified neo-epidermis at the edge of the band of bright epidermis (white arrow) (B). Immunofluorescence for Keratin 1 suggests that epithelial differentiation has commenced within the dim region (C). Later stage markers of differentiation suggest that with exception of the epithelial tip, both the bright and dim epidermis shows evidence of differentiation occurring, although the cornified cell envelope marker was only found at the very edge of the bright region (D). Quantification of the area of dim and bright regions revealed a significant change over time but no significant difference upon FBS treatment (E). Graphs in E show mean with error expressed as SEM, data analyzed using two-way ANOVA with repeated measures. Bar = 500 μm (A) and 100 μm (B-D). * p < 0.05, ****p < 0.0001.
continuous expression of keratin 1 within the suprabasal layer, indicating that early differentiation had already completed by this point. We also stained wounds for later stages of epithelial differentiation. Involucrin or occludin was absent from the tip of healing, but again present in both dim and bright regions, although often looked less well-organized in the dim region ( Figure 4D ). The cornified envelope marker loricrin was never found in dim regions but was sometimes detected toward the boundary of the bright region ( Figure 4D ). Collectively these data indicate that the brighter region reflected a more organized epidermis.
We quantified these dim and bright regions in our serumfree and 10% FBS-treated explants, where we find that the dim and bright regions are both significantly altered by time, although we find no statistically significant change between the treatments ( Figure 4E ).
DISCUSSION
Our data and other recent studies 8, 22 highlight the major advantage of ex vivo models incorporating partial thickness wounds, where complete re-epithelialization across the underlying dermal matrix can now be studied in real-time in situ. Our data show that noninvasive fluorescent imaging can be employed to longitudinally examine ex vivo wounds for several healing parameters (tissue contraction, re-epithelialization, and epidermal maturation). This may be particularly important for revealing where an intervention alters only some aspects of repair. Our approach may enable researchers to quickly identify which timepoints or healing processes would be most instructive for a subsequent more in depth assessment. Furthermore, given the variable level of healing between donors, it may be possible to use vital dyes to monitor healing progression of cultures. For example, instead of assessing on a particular day, researchers can harvest tissue once the desired level of repair has occurred. Examining wounds once the control group shows 50% healing would ensure that both positive or negative drug effects to the rate of healing can be quantified. It warrants further investigation to determine whether CMFDA en face imaging could be applied to other translational wound healing models such as porcine ex vivo skin wounds or wound organotypic human skin constructs.
While our study has utilized CMFDA and CMTPX, there are several other vital dyes that could be employed for labeling cells within the neo-epidermis. [23] [24] [25] [26] [27] [28] Moreover, by combining fluorescent dyes of different wavelengths, we demonstrate that the possibility exists to follow cell migration patterns during ex vivo healing. Our data using cell tracing suggest that re-epithelialization occurs using the extending shield mechanism previously reported for organotypic wounds.
14 This is important as skin equivalent models are highly simplified and it is unclear how well they replicate human in vivo wounds. 16 Our data do reveal that a few rare cells labeled on day 0 can persist within the neoepidermis at late stages of repair. The exact origin of these cells is unclear given that our CMFDA treatment on day 0 will also label cells within the dermis. However, the dendritic morphology suggests that they are unlikely to be keratinocytes, which alongside fibroblasts are the only two cell types typically found in artificial skin constructs.
One important conclusion of the recent Glinos et al. study is that experimental (i.e., circular) wounds often show different rates of healing within different areas of the same wound, a phenomenon that is unappreciated because of the use of histology in examining ex vivo repair. We also frequently observe irregular healing in different regions of a single wound ( Figure 4A) , with areas displaying especially pronounced centripetal migration (Figure 4A inset) . However, at this stage, we are not able to pinpoint the factors that are most critical for this. This finding is particularly important as histology of some wounds might achieve an entirely different result depending upon the plane of sectioning, further advocating en face imaging techniques in future studies.
Despite this, histology remains an essential tool for researchers in this field to understand what is happening below the wound surface or investigating wound responses such as proliferation or activation of target genes. However, combining a noninvasive assessment for global wound closure followed by end-point histology will maximize data obtained. Advanced imaging techniques constitute an exciting methodological advance in wound healing research, particularly OCT which holds the prospect of being directly applied to investigate patient wounds. 29, 30 While OCT currently remains prohibitively expensive for most ex vivo studies, CMFDA or other approaches like UV auto-fluorescence 8 may be a valid alternative as suitable equipment will be more readily available. The persistence of CMFDA within histological specimens may be especially instructive to pinpoint the wound margins, which may further aid histological assessment. In conclusion, by using a simple dye based approach we have been able to lineage trace epidermal cells and conduct an accurate intravital examination during wound re-epithelialization of human skin. This current study highlights the utility of ex vivo human skin assays, which have been frequently neglected in favor of less physiological skin equivalent cultures.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . CMFDA imaging en face highlights different regions of wounds. CMFDA images show distinctive features which were assessed (A). The area of the initial wound (uninterupted white line), the area of the open wound (white dotted line) and regions of dimly fluorescent (i.e. newly laid unstratified epidermis) and bright areas of epidermis can be delineated (white dashed line). Using brightfield microscopy the outer wound edge is visible, though other features of wounds are not obvious, while moisture within the wound adds glare that interferes with imaging (B). Bar = 500 μm.
